TIPRL and gastric cancer: Furthermore, loss of TIPRL expression serves as robust indicator for metastatic potential and unfavorable clinical outcomes in gastric cancer, where TIPRL mediates its anti-invasive effects via modulation of the AMPK/mTOR signaling axis [6].